Related Experiment Videos
[Epitopes of the envelope of the hepatitis B virus: a structural approach]
F Lema1, B Vulliez-Le Normand, F Saul
1Unité d'Immunologie Structurale, Institut Pasteur, Paris, France.
Insights
Hepatitis B virus (HBV) infection affects over 300 million people. Mapping HBV
Area of Science:
- Virology and Immunology
- Hepatitis B Virus (HBV) Pathogenesis
Context:
- Hepatitis B represents a significant global health challenge, with over 300 million individuals chronically infected.
- Infected individuals exhibit high levels of complete HBV virions and empty lipoprotein envelopes in their blood.
- The HBV envelope proteins, encoded by preS1, preS2, and S domains, are crucial components of the virion.
Purpose:
- To investigate the immunogenicity of HBV envelope proteins.
- To identify key epitopes on HBV surface proteins for potential therapeutic targets.
- To provide strategic information for developing effective Hepatitis B vaccines.
Summary:
- The preS1 and preS2 protein products are exposed on the surface of HBV virions.
- These preS proteins demonstrate higher immunogenicity compared to the S protein, with a greater number of identified epitopes.
- Three-dimensional mapping of antigenic sites on HBV is essential for understanding immune responses.
Impact:
- Understanding HBV antigenic sites can guide the development of novel vaccine strategies.
- Identification of immunogenic targets may lead to new methods for disease immunoregulation.
- This research contributes to the global effort to control and prevent Hepatitis B infection.
Abstract:
Hepatitis B is a major public health problem. More than 300 million people are chronically infected by the virus. During infection very large quantities of complete virions and empty envelopes, consisting of spherical or filamentous lipoprotein particles, are present in the blood. DNA genome coding for envelopes is divided into three domains, preS1, preS2 and S. All available data suggest that the preS1 and preS2 products are exposed at the surface of the virions. These proteins are more immunogenic than S in terms of in vivo antibody response and the number of epitopes identified. The three dimensional mapping of antigenic sites of the HBV will provide important strategic information for vaccine development and identification of targets for immunorecognition or immunoregulation of the disease.